Liotrix
- Level
- Commodity
- Parent
- 51181600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51181603This classification denotes a thyroid hormone and thyroxine-triiodothyronine drug combination with the molecular formula C30H23I7N2O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YW8HJ0N26X, more generally known as liotrix, chemically known as (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid;(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3, 5-diiodophenyl]propanoic acid, but generally known as liotrix. As of Q4 2014, LIOTRIX remains the US FDA Preferred Term for this commodity. Liotrix bears US NLM identifiers UMLS ID C0936106 and NCI Concept Code C87251. SMILES: C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O.C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N.
Same parent
Under 51181600 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51180000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.